COMMUNIQUÉS West-GlobeNewswire

Clue Transforms Period Tracking Into a Gateway to Healthcare With Launch of Free ‘Get Care’ Initiative
08/10/2026
From tracking to action, Clue connects users directly with trusted care providers across contraception, conception, metabolic and mental health, perimenopause and at-home testing, supported by partners including Novo [...]
Zoumalan, MD FACS Inc. Introduces the Bella Lift, an Upper Face Rejuvenation That Treats the Brow and Eyelids Together
08/10/2026
As new ISAPS data shows eyelid surgery now leads for both women and men worldwide, Beverly Hills oculoplastic surgeon Dr. Christopher Zoumalan explains when the brow belongs in the plan Beverly Hills, CA, Oct. 08, 2026 [...]
Ritedose Opens Advanced Laboratory and Expands Analytical Capabilities to Accelerate Pharmaceutical Innovation—Positioning the Company as a Preferred Partner for Drug Development and Manufacturing
08/10/2026
Triples laboratory footprint with the $17 million investment. Features new leachables and extractables testing capabilities. Allows for seamless development and manufacturing experience while supporting pharmaceutical [...]
Cronos Group Inc. to Hold 2026 Third Quarter Earnings Conference Call on November 5, 2026
08/10/2026
TORONTO, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2026 third quarter earnings conference call on Thursday, November 5, 2026, at 8:30 a.m. [...]
Cerenome Secures In-Network Agreement with Florida Blue for CNSide® CSF Tumor Cell Enumeration and Molecular Profile Tests
08/10/2026
First CNSide payer agreement to include CNSide’s new CSF Molecular Profile tests alongside tumor cell enumeration Expands CNSide contracted payer access to approximately 164 million covered lives HOUSTON, Oct. 08, 2026 [...]
Helus Pharma to Host Investor Presentation on October 21, 2026
08/10/2026
NEW YORK and TORONTO, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Helus Pharma Inc. (Nasdaq: HELP) (Cboe CA: HELP) (“Helus” or the “Company”), a clinical-stage pharmaceutical company committed to helping minds heal by developing [...]
Clearmind Announces Patent Publication in Japan Covering Treatment for Neurological Movement Disorder
08/10/2026
Published patent application covers 3-MMC-based treatment of dyskinesia, including in combination with Palmitoylethanolamide (PEA) Vancouver, Canada, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: [...]
Solu Therapeutics Initiates Dosing in Acute Myeloid Leukemia Cohort of the Ongoing Phase 1 Study of STX-0712
08/10/2026
BOSTON, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Solu Therapeutics, a biotechnology company pioneering novel therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced that [...]
Iantrek Expands Clinical Evidence for Bio-Interventional Ophthalmic Surgery Across Trabecular and Uveoscleral Outflow Pathways
08/10/2026
Six-month data on a new bio-reinforced canaloplasty procedure show 37% IOP reduction; new findings on bio-reinforced cyclodialysis to be presented at AAO 2026 WHITE PLAINS, N.Y., Oct. 08, 2026 (GLOBE NEWSWIRE) -- [...]
Bluesight’s 2026 Diversion Trends Report Shows Hospital Diversion Programs Maturing as Technology Use Expands
08/10/2026
ALEXANDRIA, VA, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Annual report finds software and AI adoption increasing as dedicated staffing tightens, while compliance and human reporting remain critical to diversion prevention [...]
Lisata Therapeutics Announces New Method of Use Patent Granted for Certepetide in the Treatment of Pancreatic Cancer and Other Solid Tumors
08/10/2026
LIBERTY CORNER, N.J., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company, today announced that the United States Patent and [...]
Beyond Air® Preannounces Preliminary Revenue for the Quarter Ended September 30, 2026
08/10/2026
Preliminary revenue of $2.3 million represents the highest quarterly revenue reported, and approximately 30% sequential quarterly growth and 27% growth over the same period last year Performance reflects continued [...]
ViroMissile Appoints Diane Simeone, M.D., and Matt Mulvey, Ph.D. as Advisors
08/10/2026
Appointments add scientific, clinical, and business depth as three Phase 1 intravenously-dosed oncolytic viral programs advance in the clinic SAN DIEGO, Oct. 08, 2026 (GLOBE NEWSWIRE) -- ViroMissile, Inc., a cancer [...]
Spirair Announces Publication of Multicenter Study Demonstrating Significant Six-Month Improvements with SeptAlign
08/10/2026
Six-month Vayu Study results published in Laryngoscope Investigative Otolaryngology 63 percent reduction in NOSE scores One-day median return to work 97 percent of patients would recommend the procedure to friends or [...]
Medicus Pharma Highlights Three Years of Progress and Outlines Potential Path to Long Term Value
08/10/2026
Advancing Precision Oncology and Partner-Ready Therapeutic Programs Through Capital-Efficient Development PHILADELPHIA, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) (“Medicus” or the “Company”), [...]
Enovis to Host Third Quarter 2026 Results Conference Call on November 5th
08/10/2026
Dallas, TX, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to [...]
Phathom Pharmaceuticals to Present New Data and Analyses for VOQUEZNA® (vonoprazan) at the American College of Gastroenterology (ACG) 2026 Annual Scientific Meeting
08/10/2026
Three scientific presentations will highlight new analyses of VOQUEZNA ® (vonoprazan) in GERD, including real-world patient characteristics, efficacy across BMI subgroups, and cost-effectiveness in Erosive Esophagitis [...]
Entera Bio Announces Additional Presentation of EB613 Phase 3 Study Design at the ASBMR 2026 Annual Meeting
08/10/2026
TEL AVIV, Israel, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company”), a leader in the development of oral peptides, today announced that an additional presentation highlighting [...]
MMI Raises $125M in Series D to Accelerate Commercial Growth of the Symani Surgical System Worldwide
08/10/2026
Financing will support market expansion, expand access, and advance the clinical evidence needed to broaden the role of robotic microsurgery JACKSONVILLE, Fla., Oct. 08, 2026 (GLOBE NEWSWIRE) -- MMI (Medical [...]

Pages